Free Daily Podcast Summary
Medical Device Global Market Access: Daily Summaries Delivered
by Pure Global
Navigate every market. Accelerate every launch.Medical Device Global Market Access by Pure Global is the audio briefing that turns the world’s most confusing regulatory pathways into clear, actionable roadmaps. If you’re a MedTech founder, RA/QA leader, product manager, or investor who needs to get devices cleared anywhere from Austin to Abu Dhabi, this show is your shortcut.Why listen? • Step-by-step playbooks – We decode EU MDR, U.S. 510(k), Brazil’s ANVISA, China’s NMPA, and 25 + other regimes, showing exactly how long each milestone really takes and where companies get stuck. • First-hand war stories – Hear candid interviews with regulatory veterans who have shepherded implants, software, wearables, diagnostics, and AI algorithms to market—and lived to tell the tale. • Real-time intelligence – Every episode covering the week’s new guidances, standards, and enforcement trends so you’re always ahead of the curve. • Actionable templates – From clinical evaluation checklists to t
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- Today4 min
China NMPA GMP 2026: Navigating Post-Implementation Compliance and Inspections
As of November 1, 2026, China's revised Good Manufacturing Practice (GMP) for medical devices is in full effect, replacing the 2014 version. This episode explains the immediate consequences for manufacturers, as the transition period is now over. We break down the stricter quality management system requirements from NMPA Announcement No. 107 of 2025 and discuss what NMPA inspectors will now be looking for during audits, based on the simultaneously effective 'Guidelines for Inspection of Good Manufacturing Practice.' Learn the practical steps your regulatory and quality teams must take now to ensure continued market access and avoid non-compliance penalties. Key Questions: - What are the most significant changes in China's new GMP versus the previous 2014 version? - How does the new regulation impact design controls, supplier management, and risk management? - With the transition period over, what are the immediate risks for non-compliant manufacturers? - What specific evidence will NMPA inspectors look for under the new inspection guidelines? - Are there different requirements for domestic versus foreign manufacturers? - What are the penalties for failing a GMP inspection under the new rules? - What practical steps can be taken right now to verify and ensure full compliance? Sources: - https://www.emergobyul.com/news/china-nmpa-quality-management-system-qms-legislation-take-effect-november-1-2026 - https://www.dqs-med.com/en/news/chinas-new-medical-device-gmp-in-force-from-1-nov-2026 - https://cisema.com/en/cisema-news/china-nmpa-issues-new-medical-device-gmp-inspection-guidelines/ - https://www.easymedicaldevice.com/news/medical-device-regulatory-update-november-2026/ - https://english.nmpa.gov.cn/2026-11/04/c_930869.htm How Pure Global can help: Pure Global provides end-to-end regulatory solutions to help MedTech companies navigate complex markets like China. Our local experts can conduct a comprehensive gap analysis of your QMS against the new NMPA GMP and inspection guidelines, develop a remediation plan, and assist in updating your technical documentation. With in-country representation, we act as your local contact for NMPA communications and inspection support, ensuring you maintain compliance and market presence. Our AI-powered tools streamline dossier preparation and regulatory intelligence, accelerating your path to market. Contact us at info@pureglobal.com or visit https://pureglobal.com. Explore our free AI tools and global device database at https://pureglobal.ai.
- Yesterday5 min
Australia TGA CDSS Exemption Changes: New 2026 Rules for SaMD
Australia's Therapeutic Goods Administration (TGA) has significantly narrowed the exemption criteria for Clinical Decision Support Software (CDSS), with new rules taking effect on November 1, 2026. This episode details the two key changes: exempt CDSS must not be intended to make a diagnosis on its own, and it must transparently display the logic and sources behind its recommendations for a healthcare professional to verify. We discuss how this impacts Software as a Medical Device (SaMD) manufacturers whose products may no longer qualify for exemption and will now require full TGA registration. Learn the practical steps your team must take now to assess your product, perform a gap analysis, and prepare a regulatory strategy to ensure continued market access in Australia. Key Questions: - What are the specific changes to Australia's CDSS exemption rules for 2026? - When do the new TGA requirements for SaMD take effect? - How does the TGA now define a CDSS that is exempt from regulation? - What does it mean for software to 'display its logic' for a healthcare professional? - Will my previously exempt diagnostic software now require TGA registration? - What are the first steps to take if my CDSS no longer qualifies for exemption? - How should I re-evaluate my product's claims and intended purpose? - What is the impact of these changes on AI-enabled medical software startups in Australia? Sources: - https://www.viridianlawyers.com.au/blog/saas-lawyer-australia/software-as-a-medical-device-how-the-tga-regulates-digital-health-and-ai-enabled-medical-software-startups-in-australia - https://www.medtech.org.au/september-28th-october-2nd-2026/ How Pure Global can help: Pure Global provides end-to-end regulatory consulting to help MedTech and IVD companies navigate complex global markets like Australia. Our experts can assist with re-evaluating your CDSS against the new TGA criteria, developing a comprehensive regulatory strategy if registration is now required, and acting as your official Australian Sponsor. We use advanced AI tools to efficiently compile, manage, and submit the technical dossier needed for TGA approval, streamlining your path to compliance. Whether you are a startup or a multinational, we ensure you can maintain and expand your market presence efficiently. Contact us at info@pureglobal.com, visit https://pureglobal.com, or explore our free AI tools and regulatory database at https://pureglobal.ai.
- 2 days ago5 min
India Medical Device Import Rules 2026: Proposed Expansion of Gateways
On November 3, 2026, India's Ministry of Health proposed a draft amendment to expand the list of authorized import gateways for medical devices, drugs, and cosmetics under Rule 43A of the Drugs Rules, 1945. This episode details the twelve new proposed locations, including ten Inland Container Depots (ICDs) and the new Noida International Airport. We explore the government's goal of reducing logistics costs and transit times, analyze the impact on supply chain strategies for manufacturers, and outline practical steps that regulatory and logistics teams should take now to prepare for this significant change. Key Questions: - What specific changes are proposed to India's Rule 43A for medical device imports? - Which ten new Inland Container Depots are being considered as import gateways? - How will the inclusion of Noida International Airport affect supply chains in North India? - What is the government's primary goal with this proposed expansion? - How can this change reduce logistics costs and transit times for medical device importers? - What does this mean for manufacturers currently using congested ports like Mumbai or Chennai? - Is this a final rule, or is there an opportunity for industry feedback? - What practical steps should regulatory and supply chain teams take in response to this proposal? Sources: - https://www.thehindu.com/sci-tech/health/centre-proposes-10-new-import-gateways-for-drugs-medical-devices/article68828485.ece - https://maritimegateway.com/india-proposes-wider-import-gateway-network-for-medicines-and-medical-devices/ - https://www.business-standard.com/policy/centre-proposes-expanding-import-gateways-for-drugs-medical-devices-126110300424_1.html How Pure Global can help: Pure Global provides end-to-end regulatory consulting for MedTech and IVD companies, helping them access global markets faster. Our experts develop efficient regulatory strategies, manage technical dossier submissions using advanced AI, and act as your local representative in over 30 markets, including India. We help you navigate complex requirements, from initial market research to post-market surveillance, ensuring your products remain compliant. To learn how Pure Global can streamline your market access, visit us at https://pureglobal.com, contact us at info@pureglobal.com, or explore our free regulatory AI tools and database at https://pureglobal.ai.
- 3 days ago4 min
Tanzania TMDA Medical Device Registration Fees 2027: Key Deadlines
The Tanzania Medicines and Medical Devices Authority (TMDA) has announced its annual retention fee schedule for 2027, introducing critical deadlines that medical device manufacturers must meet to maintain market access. This episode details the multi-stage process, starting with the mandatory continued-marketing declaration due by November 1, 2026. We break down the fee structure—USD 200 per registered device and USD 50 per notified device—and the final payment deadline of January 31, 2027. We also explain the severe consequences of non-compliance, including registration suspension and import permit blocks, which take effect from April 1, 2027. Tune in for practical steps your team can take now to prepare for these requirements and avoid costly disruptions to your business in Tanzania. Key Questions: - What are the key deadlines for Tanzania's 2027 medical device retention fees? - How much are the annual fees for registered and notified medical devices in Tanzania? - What is the continued-marketing declaration and why is the November 1, 2026 deadline so important? - What happens if manufacturers miss the TMDA's payment deadline of January 31, 2027? - Why is the April 1, 2027 date critical for maintaining market access in Tanzania? - What immediate steps should regulatory teams take to prepare for these requirements? - How can companies avoid registration suspension and import permit blocks for their devices? - What are the financial and logistical implications of TMDA's 2027 fee schedule for manufacturers? - How should companies coordinate with their local Tanzanian representatives for this process? Sources: - https://pureglobal.com/news/medical-device-regulatory-news-and-updates/ How Pure Global can help: Pure Global provides end-to-end regulatory consulting to help MedTech companies access and maintain their presence in over 30 global markets, including Tanzania. Our local experts can act as your in-country representative, manage submission of declarations, and ensure timely fee payments to authorities like the TMDA. We leverage advanced AI and data tools to develop efficient regulatory strategies, compile technical dossiers, and monitor changes that impact your registrations. Whether you need to manage annual renewals or expand into new markets, Pure Global streamlines the process. Visit us at https://pureglobal.com, contact us at info@pureglobal.com, or explore our free regulatory AI tools and device database at https://pureglobal.ai.
- 4 days ago4 min
Brazil ANVISA Recognized Technical Standards: New Lists for Orthopedic and Health-Use Materials
On October 22, 2026, Brazil's ANVISA released three workbooks of recognized technical standards impacting medical device manufacturers. This episode details the contents of the new "Transversal Standards" (v1.0) and "Health-Use Materials" (v0.0) lists, as well as the updated "Orthopedic Implantable Materials" (v1.1) list. We explain how voluntary compliance with these standards can create a presumption of conformity, potentially streamlining the review of technical dossiers. We cover which device categories are affected and provide practical steps for regulatory teams to perform a gap analysis and update their submission strategies for the Brazilian market. Key Questions: - What are the three new technical standard lists ANVISA published on October 22, 2026? - How do these recognized standards impact the review process for medical device submissions in Brazil? - Which specific device types are affected by the new lists for orthopedic and health-use materials? - What is the significance of the new "transversal standards" list for all device manufacturers? - Is compliance with these ANVISA-recognized standards mandatory? - How can referencing these standards streamline your technical dossier preparation? - What practical steps should your regulatory team take in response to these updates? - Why is it important to monitor these ANVISA workbooks for future versions? Sources: - https://www.pure-global.com/insights/anvisa-publishes-three-recognized-device-standards-lists How Pure Global can help: Pure Global provides end-to-end regulatory consulting to help MedTech companies access global markets faster. Our experts can help you navigate complex regulatory changes, such as ANVISA's new recognized technical standards, by developing a clear market access strategy, performing gap analyses, and compiling robust technical dossiers that meet local requirements. With a presence in over 30 countries, we act as your local representative and ensure ongoing compliance. Visit us at https://pureglobal.com or contact us at info@pureglobal.com. Explore our free AI regulatory tools and global device database at https://pureglobal.ai to streamline your research and submissions.
- 5 days ago5 min
South Korea MFDS Proposes 'One-Stop' Certification for Class II Medical Devices
South Korea's Ministry of Food and Drug Safety (MFDS) has proposed a significant amendment to streamline the certification process for Class II medical devices. This episode details the new 'one-stop' pathway, which combines the technical document review and certification application into a single, simultaneous submission to the National Institute of Medical Device Safety Information (NIDS). We explore how this change is expected to reduce the total processing time from approximately 40 days to 25 days and offer practical advice for manufacturers to prepare for this accelerated market access route following the closure of the public comment period on October 26, 2026. Key Questions: - What is South Korea's MFDS proposing for Class II medical device certification? - How does the new 'one-stop' process differ from the current sequential system? - What is the expected reduction in review time for Class II devices? - What is the role of the National Institute of Medical Device Safety Information (NIDS) in the new process? - When did the public comment period for this proposed amendment close? - How can manufacturers prepare their technical documentation for this potential change? - Why is a complete and accurate initial submission more critical under a simultaneous review process? - What practical steps should regulatory teams take to leverage this accelerated pathway? - How could this change impact market entry timelines and commercial strategy? Sources: - https://www.gca-korea.com/post/korean-mfds-to-introduce-a-one-stop-certification-and-review-process-for-class-ii-medical-devices - https://www.youtube.com/watch?v=example_placeholder_for_25 How Pure Global can help: Pure Global streamlines global market access for MedTech and IVD companies. For South Korea, we act as your local representative, manage interactions with the MFDS and NIDS, and prepare your technical dossier for submission. Our experts can help you navigate the proposed 'one-stop' certification process for Class II devices, ensuring your submission is complete and accurate to maximize the benefits of the accelerated timeline. We combine local expertise with advanced AI to get your products to market faster. Visit https://pureglobal.com, email us at info@pureglobal.com, or explore our free AI tools and device database at https://pureglobal.ai.
- 6 days ago4 min
FDA IDE Electronic Submission Guidance: Preparing for the New Template
This episode covers the US FDA's new draft guidance, released on October 27, 2026, which introduces a standardized 'Electronic Submission Template for Investigational Device Exemption (IDE) Applications.' We discuss the FDA's goals of improving submission consistency and review efficiency, the key components of the proposed template, and who will be most affected. We also highlight the critical December 28, 2026, deadline for industry feedback and provide practical steps for regulatory and clinical teams to prepare for this upcoming change. Key Questions: - What is the new FDA draft guidance on IDE electronic submissions? - Why is the FDA introducing a standardized template for IDE applications? - Who will be most affected by this proposed change? - What is the critical deadline for providing feedback to the FDA on this draft guidance? - How does the new template aim to improve the IDE review process? - What are the key sections of the proposed electronic submission template? - What practical steps should regulatory teams take in response to this draft guidance? - How can sponsors prepare their internal processes for this new format? Sources: - https://www.federalregister.gov/documents/2026/10/28/2026-23501/electronic-submission-template-for-investigational-device-exemption-ide-applications-draft - https://www.fda.gov/regulatory-information/search-fda-guidance-documents/electronic-submission-template-investigational-device-exemption-ide-applications - https://www.fda.gov/medical-devices/news-events-medical-devices/cdrh-new-news-and-updates How Pure Global can help: Pure Global provides end-to-end regulatory consulting to help MedTech companies access global markets faster. Our experts can help you navigate the new FDA IDE submission requirements, develop an efficient regulatory strategy for your US clinical trials, and compile your technical dossier using advanced AI tools. We act as your local representative and ensure your submissions are complete and compliant to minimize delays. For support with your market access strategy, visit us at https://pureglobal.com or contact us at info@pureglobal.com. Explore our free AI regulatory tools and device database at https://pureglobal.ai.
- 1 weeks ago5 min
Brazil ANVISA Medical Device Recall October 2026: Rota-Strip, CLOSURERFS, and BD Catheters
Brazil's health authority, ANVISA, announced on October 23, 2026, the suspension and recall of several medical devices due to significant compliance failures. This episode details the specific products affected, including the Rota-Strip diagnostic test, the CLOSURERFS radiofrequency ablation stylet, and certain lots of the BD Angioccath catheter. We analyze the reasons behind each recall—from unsatisfactory test results to manufacturing non-compliance—and discuss the broader implications for manufacturers. The focus is on the critical importance of adhering to Good Manufacturing Practices (GMP) and maintaining a robust post-market surveillance system to ensure continued market access in Brazil. Key Questions: - What specific medical devices did ANVISA recall in its October 2026 announcement? - Why was the Rota-Strip diagnostic test suspended from the Brazilian market? - What manufacturing non-compliance led to the recall of Covidien's CLOSURERFS stylet? - Which lots of the BD Angioccath catheter were recalled and what was the associated risk? - What do these enforcement actions reveal about ANVISA's approach to post-market surveillance? - How does this event impact GMP requirements for medical device manufacturers in Brazil? - What are the essential components of an effective post-market surveillance plan for the Brazilian market? - What immediate, practical steps should regulatory and quality teams take in response to this news? Sources: - https://www.portal.afya.com.br/noticias/anvisa-suspende-e-recolhe-dispositivos-medicos-irregulares - https://conexaogeral.com.br/anvisa-suspende-teste-para-rotavirus-e-determina-recolhimento-de-dispositivos-medicos/ How Pure Global can help: Pure Global provides comprehensive regulatory consulting to help MedTech and IVD companies navigate complex markets like Brazil. Our experts offer end-to-end support, from developing a regulatory strategy and compiling technical dossiers to securing ANVISA registration and GMP certification. We also act as your Brazil Registration Holder and provide post-market surveillance services to ensure ongoing compliance. With our deep local expertise and advanced AI tools, we streamline the path to market access, helping you launch your products faster and maintain them compliantly. Contact us at info@pureglobal.com, visit https://pureglobal.com, or explore our free AI tools and database at https://pureglobal.ai.
Get Medical Device Global Market Access summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
FDA Watch
A regulatory expert hosts discussions on FDA policies and developments across pharmaceuticals, devices, food, and cosmetics.
Health Discovered
Doctors explore surprising stories to uncover insights about health and well-being.
Out of the Gray (Gy) - Standard Imaging
Conversations with experts in radiation oncology exploring advancements in technology, research, and clinical practice.
Health vs Hype with the American Medical Association
A medical expert debunks viral health trends and misinformation with science-backed insights from physicians.
Made for Health | Peptides | Lyme | Chronic Infections | Long Covid | Insulin Resistance | Hypermobility
A physician explores science-based approaches to treating chronic conditions and restoring health.
The Biohacking Standards
A deep dive into biohacking fundamentals—nutrition, movement, sleep, and mindfulness—grounded in science and holistic wellness principles.
Get Better Faster
Doctors and researchers discuss functional medicine and root-cause approaches to chronic illness and health optimization.
Health Check
BBC World Service
The Curbsiders Internal Medicine Podcast
Expert-led internal medicine discussions with clinical insights and humor for primary care and hospital medicine providers.
The VPZD Show
Two physicians discuss healthcare, medicine, and policy from a contrarian, middle-ground perspective.
Frankly Speaking About Family Medicine
Discusses current topics and developments in primary care and family medicine.
This Week in Cardiology
A weekly summary and analysis of key developments in cardiology for healthcare professionals.
About Medical Device Global Market Access
Navigate every market. Accelerate every launch.Medical Device Global Market Access by Pure Global is the audio briefing that turns the world’s most confusing regulatory pathways into clear, actionable roadmaps. If you’re a MedTech founder, RA/QA leader, product manager, or investor who needs to get devices cleared anywhere from Austin to Abu Dhabi, this show is your shortcut.Why listen? • Step-by-step playbooks – We decode EU MDR, U.S. 510(k), Brazil’s ANVISA, China’s NMPA, and 25 + other regimes, showing exactly how long each milestone really takes and where companies get stuck. • First-hand war stories – Hear candid interviews with regulatory veterans who have shepherded implants, software, wearables, diagnostics, and AI algorithms to market—and lived to tell the tale. • Real-time intelligence – Every episode covering the week’s new guidances, standards, and enforcement trends so you’re always ahead of the curve. • Actionable templates – From clinical evaluation checklists to t
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Medical Device Global Market Access in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Medical Device Global Market Access daily summary?
It's a free AI-powered email that summarizes new episodes of Medical Device Global Market Access as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Medical Device Global Market Access podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Medical Device Global Market Access product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Pure Global.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does Medical Device Global Market Access release new episodes?
Medical Device Global Market Access publishes daily. Our AI generates a summary within hours of each new episode.
What topics does Medical Device Global Market Access cover?
Medical Device Global Market Access covers topics including Technology. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Medical Device Global Market Access summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.